Singapore: Malaysian Bio-XCell and Agila Biotech have sealed US$34.4million (RM107million) build-and-lease agreement dur...
Singapore: Dengue has gripped Malaysia in a deadly epidemic with more than 48,000 people falling victim to the disease t...
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Sanofi announced that the phase III clinical trials for its dengue vaccine was successful, in a press confere...
Singapore: US-based BioElectronics, the maker of unique pain relief, inexpensive, patented, consumer medical devices, ha...
Singapore: Medical tourism, easy regulatory guidelines, a lack of strict price regulation and an increasing elderly popu...
The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US...
Singapore: Malaysian Biotechnology Corporation (BiotechCorp), the organization involved in nurturing biotechnology comp...
